Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,258 | 475 | 97.7% |
| Education | $216.36 | 12 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,110 | 102 | $0 (2024) |
| Novo Nordisk Inc | $2,004 | 93 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,668 | 104 | $0 (2024) |
| Lilly USA, LLC | $953.13 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $612.74 | 32 | $0 (2024) |
| PFIZER INC. | $594.76 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $275.70 | 17 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $206.50 | 12 | $0 (2022) |
| Amgen Inc. | $196.12 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $171.10 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,108 | 35 | Novo Nordisk Inc ($424.33) |
| 2023 | $749.55 | 39 | Novo Nordisk Inc ($211.32) |
| 2022 | $1,156 | 37 | Novo Nordisk Inc ($369.46) |
| 2021 | $1,150 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($230.92) |
| 2020 | $1,395 | 79 | AstraZeneca Pharmaceuticals LP ($233.31) |
| 2019 | $1,087 | 62 | AstraZeneca Pharmaceuticals LP ($396.88) |
| 2018 | $1,297 | 75 | AstraZeneca Pharmaceuticals LP ($428.74) |
| 2017 | $1,532 | 97 | AstraZeneca Pharmaceuticals LP ($322.75) |
All Payment Transactions
487 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Obesity | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: DIABETES | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $116.06 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Diabetes | ||||||
| 08/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.27 | General |
| Category: Obesity | ||||||
| 05/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: DIABETES | ||||||
| 05/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,101 | 1,899 | $147,240 | $93,470 |
| 2022 | 18 | 1,354 | 2,201 | $161,992 | $104,974 |
| 2021 | 19 | 1,451 | 2,291 | $161,143 | $105,485 |
| 2020 | 19 | 1,303 | 1,862 | $126,635 | $76,188 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 225 | 471 | $50,610 | $29,054 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 231 | $34,600 | $21,803 | 63.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 150 | 150 | $22,500 | $18,935 | 84.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 32 | 32 | $6,080 | $5,162 | 84.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $5,040 | $4,532 | 89.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 221 | 476 | $9,520 | $3,998 | 42.0% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 110 | 315 | $9,450 | $2,999 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $4,000 | $2,791 | 69.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 74 | $2,590 | $2,231 | 86.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,090 | $1,778 | 85.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 30 | 40 | $440.00 | $136.40 | 31.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 16 | $320.00 | $51.36 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 494 | $49,400 | $31,999 | 64.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $23,700 | $20,548 | 86.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 210 | $31,450 | $20,454 | 65.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 39 | 39 | $7,410 | $6,476 | 87.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 70 | 70 | $4,900 | $4,798 | 97.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 23 | $4,600 | $3,152 | 68.5% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 111 | 306 | $9,180 | $2,934 | 32.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 21 | 21 | $4,200 | $2,755 | 65.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 87 | 87 | $2,665 | $2,553 | 95.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,470 | $2,153 | 87.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,000 | $1,989 | 66.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 123 | 126 | $5,040 | $1,674 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 239 | 508 | $10,160 | $1,511 | 14.9% |
About Dr. David Haden, M.D
Dr. David Haden, M.D is a Internal Medicine healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316989718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Haden, M.D has received a total of $9,475 in payments from pharmaceutical and medical device companies, with $1,108 received in 2024. These payments were reported across 487 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($9,258).
As a Medicare-enrolled provider, Haden has provided services to 5,209 Medicare beneficiaries, totaling 8,253 services with total Medicare billing of $380,116. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Virginia Beach, VA
- Active Since 06/11/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316989718
Products in Payments
- JARDIANCE (Drug) $1,388
- FARXIGA (Drug) $1,226
- Ozempic (Drug) $1,025
- MOUNJARO (Drug) $338.34
- TRELEGY ELLIPTA (Drug) $321.03
- BREZTRI (Drug) $303.73
- Wegovy (Drug) $276.51
- STIOLTO RESPIMAT (Drug) $263.32
- TRULICITY (Drug) $214.18
- SYMBICORT (Drug) $211.95
- CHANTIX (Drug) $209.44
- Tresiba (Drug) $186.85
- XARELTO (Drug) $183.86
- Rybelsus (Drug) $175.28
- Victoza (Drug) $169.48
- AIRSUPRA (Drug) $163.52
- SHINGRIX (Biological) $155.96
- NURTEC ODT (Drug) $147.91
- Prolia (Biological) $127.67
- Saxenda (Drug) $122.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Virginia Beach
Dr. Garfield Samuels, M.d, M.D
Internal Medicine — Payments: $144,009
Anthony Amabile, Md, MD
Internal Medicine — Payments: $13,478
Herbert Knight, M.d, M.D
Internal Medicine — Payments: $11,019
Vera Goode, Md, MD
Internal Medicine — Payments: $8,369
Rajul Malik, Md, MD
Internal Medicine — Payments: $6,478
Susan Ring, Md, MD
Internal Medicine — Payments: $5,413